¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"nonionic contrast agent"¿¡ ´ëÇÑ KI ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
radioopaque agent
¹æ»ç¼±ºñÅõ°ú¼ºÁ¦Àç
radioprotective agent
¹æ»ç¼±¹æÈ£Á¦
sclerosing agent
°æÈ¾à
therapeutic agent
Ä¡·á¾à
thrombolytic agent
Ç÷Àü¿ëÇØ¾à
3D phase contrast angiography
3Â÷¿øÀ§»ó´ëÁ¶ Ç÷°üÃÔ¿µ¼ú
barium contrast medium
¹Ù·ýÁ¶¿µÁ¦
blood oxygenation level dependant contrast
Ç÷Áß»ê¼ÒÄ¡ÀÇÁ¸´ëÁ¶µµ
CE [=contrast enhancement]
Á¶¿µÁõ°
CE FAST [=contrast enhanced fast acquisition in the steady state]
Ç×Á¤»óÅÂÀÇ ´ëÁ¶µµÁõ°°í¼Óȹµæ
contrast
´ëÁ¶, ´ëºñ, Á¶¿µ
contrast enema
Á¶¿µ°üÀå
contrast enhancement [=CE]
Á¶¿µÁõ°
contrast enhancement ratio
Á¶¿µÁõ°ºñ
contrast enhancement scan
Á¶¿µÁõ°½ºÄµ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½